England’s High Court has ruled it is lawful to use Roche’s Avastin (bevacizumab) in an unlicensed use in wet age-related macular degeneration (AMD) instead of more expensive approved drugs from Novartis and Bayer. While NHS organisations welcomed ...
Original Article: Novartis, Bayer consider appeal as court says Avastin can be used in AMD